compounding semaglutide at home Photon Launches an At-Home Compounded GLP-1 Bioreactor Drugmakers battle pharmacies over compounded

Result: 30% higher osteoporosis risk

This affordability equation is expected to shift significantly after the patent on Semaglutide expires in China and India in 2026

h1 { line-height: 1em

3094 Gastrointestinal (GI) Injury Allegations MDL 3094 consolidates claims alleging that certain GLP1 receptor agonists (and related incretin therapies) caused or contributed to gastrointestinal injuries such as gastroparesis, ileus/intestinal obstruction, and gallbladderrelated events

Retatrutide is being hailed as a trillion-dollar weight-loss breakthrough that also spares muscle

If GLP-1 medication helped you achieve significant weight loss but left your face looking hollow, tired, or older than you expected, you are not alone